Psychiatrist.com Home
Keyword Search
A Fresh Look at Monoamine Oxidase Inhibitors for Depression
Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP (Co-Chair), David A. Sclar, BPharm, PhD (Co-Chair), et al
Coming soon...
1 Credit [Coming soon...]
Depression Epidemiology and Its Treatment Evolution
Robert M. A. Hirschfeld, MD
About 20% of US adults have a depressive episode at some point. Read this activity to review the prevalence and burden of depression and to understand how depression treatments came about.
0.5 Credit [See the entire activity]
MAOIs and Depression Treatment Guidelines
Michael E. Thase, MD
MAOIs were once a cornerstone of depression treatment and treatment guidelines still acknowledge their role. Here, find out what practice guidelines recommend—when to prescribe MAOIs and for whom.
0.5 Credit [See the entire activity]
An Update on MAOIs: Dietary Restrictions and Drug Interactions
David A. Flockhart, MD, PhD
Coming soon...
0.5 Credit [Coming soon...]
MAOIs and Transdermal Delivery
Chad M. VanDenBerg, PharmD, BCPP
Dietary restrictions are a large part of why physicians are hesitant to prescribe MAOIs. Read this activity to find out about the mechanizm of action of a newer MAOI formulation that may be easier to administer to certain patients with depression.
0.5 Credit [See the entire activity]
MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure
Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP (Co-Chair), and David A. Sclar, BPharm, PhD (Co-Chair)
Coming soon...
0.5 Credit [Coming soon...]
The Use of MAOIs in Primary Care
Larry Culpepper, MD, MPH
Newer developments in antidepressant formulations may make MAOIs easier for PCPs to prescribe. Learn about the safety and efficacy of MAOIs and find out which of your patients may best respond to these agents.
0.5 Credit [See the entire activity]
